Tumor Suppressive Functions of p53

  1. Jack T. Zilfou1 and
  2. Scott W. Lowe2,3
  1. 1Zilfou Therapeutics, Inc., Allentown, Pennsylvania 18104
  2. 2Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724
  3. 3Howard Hughes Medical Institute, Cold Spring Harbor, New York 11724
  1. Correspondence: jackzilfou{at}verizon.net

Abstract

The majority of human cancers acquire mutations that abrogate the p53 tumor suppressor network and, as a consequence, p53 is one of the most extensively studied proteins in cancer research. Because of its potent tumor suppressive activity, it is widely assumed that a molecular understanding of p53 action will produce fundamental insights into natural processes that limit tumorigenesis and may identify key molecular targets for therapeutic intervention. p53 functions largely as a transcription factor, and can trigger a variety of antiproliferative programs by activating or repressing key effector genes. Despite a significant body of literature detailing the biochemical and biological functions of p53, much remains to be elucidated. Indeed, the p53 network is as complex and enigmatic as it is relevant. It is the goal of this article, written 30 years after the discovery of p53, to present a concise review of the tumor suppressor role of the p53 network and to highlight the context-dependent nature of p53 target-gene functions.

Footnotes

  • Editors: Arnold J. Levine and David Lane

  • Additional Perspectives on The p53 Family available at www.cshperspectives.org



Also in this Collection

      | Table of Contents

      This Article

      1. Cold Spring Harb. Perspect. Biol. 1: a001883 Copyright © 2009 Cold Spring Harbor Laboratory Press; all rights reserved

      Article Category

      Updates/Comments

      1. Submit Updates/Comments
      2. No Updates/Comments published

      Subject Collections

      1. The p53 Family

      Share

      In this Collection